ZETAGEN THERAPEUTICS, INC. — Form D
ZETAGEN THERAPEUTICS, INC. of SYRACUSE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-13. The offering totals $1.7M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-13
- Form: D
- Accession: 0001730728-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.7M
- Minimum investment: $10K
- Investors: 47
- Date of first sale: 2017-01-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-305466
Issuer
- Name: ZETAGEN THERAPEUTICS, INC.
- CIK: 0001730728
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 841 EAST FAYETTE STREET, SYRACUSE, NY, 13210
- Phone: 315-475-2200
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Joe C Loy | Director | Weatherford, TX |
| Joe C Loy | Executive Officer | Weatherford, TX |
| Richard C Warburg | Director | Bethesda, MD |
| Ashok C Kaveeshwar | Director | Bethesda, MD |
| Nikhil Thakur, MD | Director | Andover, MA |
| Nikhil Thakur, MD | Executive Officer | Andover, MA |
| Donald C Brown | Director | Hopkinton, MA |
| David B Tischler | Director | San Francisco, CA |
| David B Tischler | Executive Officer | San Francisco, CA |
| Peter B Finn | Director | Boston, MA |
| Peter B Finn | Executive Officer | Boston, MA |
Other filings by this issuer (5)
More